Dinmohamed AG , Brink M , Visser O , et al. Population based analyses among 184 patients diagnosed with large granular lymphocyte leukemia in the Netherlands between 2001 and 2013. Leukemia 2016; 30(6): 1449–1451.

Dinmohamed AG , Brink M , Visser O , et al. Population based analyses among 184 patients diagnosed with large granular lymphocyte leukemia in the Netherlands between 2001 and 2013. Leukemia 2016; 30(6): 1449–1451.)| false
• Search Google Scholar
• Export Citation

Shah MV , Hook CC , Call TG , Go RS . A population-based study of large granular lymphocyte leukemia. Blood Cancer J 2016; 6(8): e455.

Shah MV , Hook CC , Call TG , Go RS . A population-based study of large granular lymphocyte leukemia. Blood Cancer J 2016; 6(8): e455.)| false
• Search Google Scholar
• Export Citation

Swerdlow SH , Campo E , Pileri SA , et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 127(20): 2375–2390.

Swerdlow SH , Campo E , Pileri SA , et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 127(20): 2375–2390.)| false
• Search Google Scholar
• Export Citation

Lundell R , Hartung L , Hill S , et al. T-cell large granular lymphocyte leukemias have multiple phenotypic abnormalities involving pan-T-cell antigens and receptors for MHC molecules. Am J Clin Pathol 2005; 124(6): 937–946.

Lundell R , Hartung L , Hill S , et al. T-cell large granular lymphocyte leukemias have multiple phenotypic abnormalities involving pan-T-cell antigens and receptors for MHC molecules. Am J Clin Pathol 2005; 124(6): 937–946.)| false
• Search Google Scholar
• Export Citation

Yang J , Epling-Burnette PK , Painter JS , et al. Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia. Blood 2008; 111(3): 1610–1616.

Yang J , Epling-Burnette PK , Painter JS , et al. Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia. Blood 2008; 111(3): 1610–1616.)| false
• Search Google Scholar
• Export Citation

Koskela HLM , Eldfors S , Ellonen P , et al. Somatic STAT3 mutations in large granular lymphocytic leukemia. N Engl J Med 2012; 366(20): 1905–1913.

Koskela HLM , Eldfors S , Ellonen P , et al. Somatic STAT3 mutations in large granular lymphocytic leukemia. N Engl J Med 2012; 366(20): 1905–1913.)| false
• Search Google Scholar
• Export Citation

Fasan A , Kern W , Grossmann V , et al. STAT3 mutations are highly specific for large granular lymphocytic leukemia. Leukemia 2013; 27(7): 1598–1600.

Fasan A , Kern W , Grossmann V , et al. STAT3 mutations are highly specific for large granular lymphocytic leukemia. Leukemia 2013; 27(7): 1598–1600.)| false
• Search Google Scholar
• Export Citation

https://www.nccn.org/professionals/physician_gls/pdf/t-cell.pdf.

Lamy T , Moignet A , Loughran TP, Jr . LGL leukemia: from pathogenesis to treatment. Blood 2017; 129(9): 1082–1094.

Lamy T , Moignet A , Loughran TP, Jr . LGL leukemia: from pathogenesis to treatment. Blood 2017; 129(9): 1082–1094.)| false
• Search Google Scholar
• Export Citation

Lamy T , Liu JH , Landowski TH , et al. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia. Blood 1998; 92(12): 4771–4777.

Lamy T , Liu JH , Landowski TH , et al. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia. Blood 1998; 92(12): 4771–4777.)| false
• Search Google Scholar
• Export Citation

Liu JH , Wei S , Lamy T , et al. Blockade of Fas-dependent apoptosis by soluble Fas in LGL leukemia. Blood 2002; 100(4): 1449–1453.

Liu JH , Wei S , Lamy T , et al. Blockade of Fas-dependent apoptosis by soluble Fas in LGL leukemia. Blood 2002; 100(4): 1449–1453.)| false
• Search Google Scholar
• Export Citation

Yang J , Epling-Burnette PK , Painter JS , et al. Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia. Blood 2008; 111(3): 1610–1616.

Yang J , Epling-Burnette PK , Painter JS , et al. Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia. Blood 2008; 111(3): 1610–1616.)| false
• Search Google Scholar
• Export Citation

Teramo A , Gattazzo C , Passeri F , et al. Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia. Blood 2013; 121(19): 3843–3854.

Teramo A , Gattazzo C , Passeri F , et al. Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia. Blood 2013; 121(19): 3843–3854.)| false
• Search Google Scholar
• Export Citation

Epling-Burnette PK , Liu JH , Catlett-Falcone R , et al. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest 2001; 1073: 351–362.

Epling-Burnette PK , Liu JH , Catlett-Falcone R , et al. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest 2001; 1073: 351–362.)| false
• Search Google Scholar
• Export Citation

Wang Y , Shen Y , Wang S , et al. The role of STAT3 in leading the crosstalk between human cancers and the immune system. Cancer Lett 2018; 415: 117–128.

Wang Y , Shen Y , Wang S , et al. The role of STAT3 in leading the crosstalk between human cancers and the immune system. Cancer Lett 2018; 415: 117–128.)| false
• Search Google Scholar
• Export Citation

Milner, JD , Vogel TP , Forbes L , et al. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood 2015; 125: 591–599.

Milner, JD , Vogel TP , Forbes L , et al. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood 2015; 125: 591–599.)| false
• Search Google Scholar
• Export Citation

Chen X , Bai F , Sokol L , et al. A critical role for DAP10 and DAP12 in CD8+ T cell-mediated tissue damage in large granular lymphocyte leukemia. Blood 2009; 113(14): 3226–3234.

Chen X , Bai F , Sokol L , et al. A critical role for DAP10 and DAP12 in CD8+ T cell-mediated tissue damage in large granular lymphocyte leukemia. Blood 2009; 113(14): 3226–3234.)| false
• Search Google Scholar
• Export Citation

Fedor I , Zöld É , Barta Zs . The extraintestinal spectrum of gluten sensitivity. [A gluténérzékenység extraintestinalis spektruma]. Orv Hetil 2019; 160(34): 1327–1334. [Hungarian].

Fedor I , Zöld É , Barta Zs . The extraintestinal spectrum of gluten sensitivity. [A gluténérzékenység extraintestinalis spektruma]. Orv Hetil 2019; 160(34): 1327–1334. [Hungarian].)| false
• Search Google Scholar
• Export Citation

Dumitriu B , Ito S , Feng X , et al. Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study. Lancet Haematol 2016; 3(1): e22–9.

Dumitriu B , Ito S , Feng X , et al. Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study. Lancet Haematol 2016; 3(1): e22–9.)| false
• Search Google Scholar
• Export Citation

Adamkovich N , Kispál M , Krenács L , et al. Nagy, granulált citoplazmájú lymphocytás leukaemia – Ritka betegség, személyre szabott kezelési lehetőségekkel. Orv. Hetil 2014; 155(11): 414–419.

Adamkovich N , Kispál M , Krenács L , et al. Nagy, granulált citoplazmájú lymphocytás leukaemia – Ritka betegség, személyre szabott kezelési lehetőségekkel. Orv. Hetil 2014; 155(11): 414–419.)| false
• Search Google Scholar
• Export Citation

Braunstein Z , Mishra A , Staub A , et al. Clinical outcomes in T-cell large granular lymphocytic leukaemia: prognostic factors and treatment response. Br J Haematol 2021 Feb; 192(3): 484–493.

Braunstein Z , Mishra A , Staub A , et al. Clinical outcomes in T-cell large granular lymphocytic leukaemia: prognostic factors and treatment response. Br J Haematol 2021 Feb; 192(3): 484–493.)| false
• Search Google Scholar
• Export Citation

Sanikommu SR , Clemente MJ , Chomczynski P , et al. Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL). Leuk Lymphoma 2018 Feb; 59(2): 416–422.

Sanikommu SR , Clemente MJ , Chomczynski P , et al. Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL). Leuk Lymphoma 2018 Feb; 59(2): 416–422.)| false
• Search Google Scholar
• Export Citation

Rosamilio R , Giudice V , Ferrara I , et al. Prolonged complete hematologic response in relapsed/refractory T-large granular lymphocyte leukemia after bendamustine treatment. Transl Med Unisa 2016; 15: 80–83.

Rosamilio R , Giudice V , Ferrara I , et al. Prolonged complete hematologic response in relapsed/refractory T-large granular lymphocyte leukemia after bendamustine treatment. Transl Med Unisa 2016; 15: 80–83.)| false
• Search Google Scholar
• Export Citation